CN Patent

CN116459250A — 检测和治疗生长激素缺乏症

Assigned to Lumos Pharma Inc · Expires 2023-07-21 · 3y expired

What this patent protects

本文描述了使用用于检测生长激素(GH)缺乏症(GHD)的MK‑0677的新口服方法。还描述了治疗具有功能性下丘脑‑垂体GH轴的儿童的生长激素(GH)缺乏症(GHD)的方法。

USPTO Abstract

本文描述了使用用于检测生长激素(GH)缺乏症(GHD)的MK‑0677的新口服方法。还描述了治疗具有功能性下丘脑‑垂体GH轴的儿童的生长激素(GH)缺乏症(GHD)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116459250A
Jurisdiction
CN
Classification
—
Expires
2023-07-21
Drug substance claim
No
Drug product claim
No
Assignee
Lumos Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.